Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in accordance with our internal policy on disclosure of events and information, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has made a disclosure to BSE under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015, following its internal policy on disclosure of events and information. The full text of the filing was truncated in the headline, so the specific event, decision, or information being disclosed could not be determined. The company has simply notified the exchange of a material event in compliance with listing rules. No specific financial figures, order details, or product information were visible in the available text.
Without visibility into the actual content of the disclosure, it is not possible to determine the impact on shareholders or the stock price. Investors should check the full filing on BSE/NSE to understand the nature of the event.